VivoSim Labs, Inc.
VIVS
$1.94
$0.05933.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -49.59% | -72.01% | -83.60% | -70.54% | -85.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -49.59% | -72.01% | -83.60% | -70.54% | -85.83% |
| Cost of Revenue | -47.05% | -49.29% | -45.06% | -38.12% | 116.23% |
| Gross Profit | 46.98% | 48.39% | 43.18% | 36.71% | -236.78% |
| SG&A Expenses | -26.47% | -21.55% | -5.07% | 5.22% | 12.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -36.63% | -35.04% | -24.99% | -16.05% | 47.43% |
| Operating Income | 36.48% | 34.34% | 23.60% | 14.92% | -66.62% |
| Income Before Tax | 35.11% | 33.10% | 22.61% | 15.00% | -62.98% |
| Income Tax Expenses | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 35.11% | 33.09% | 22.60% | 15.00% | -62.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.11% | 33.09% | 22.60% | 15.00% | -62.97% |
| EBIT | 36.48% | 34.34% | 23.60% | 14.92% | -66.62% |
| EBITDA | 37.02% | 34.68% | 23.85% | 15.09% | -68.33% |
| EPS Basic | 60.20% | 49.63% | 31.27% | 14.51% | -74.98% |
| Normalized Basic EPS | 60.53% | 49.93% | 31.45% | 14.60% | -78.30% |
| EPS Diluted | 60.11% | 49.54% | 31.18% | 14.51% | -74.98% |
| Normalized Diluted EPS | 60.53% | 49.93% | 31.45% | 14.60% | -78.30% |
| Average Basic Shares Outstanding | 72.24% | 93.13% | 126.52% | 241.03% | 1,215.84% |
| Average Diluted Shares Outstanding | 72.24% | 93.13% | 126.52% | 241.03% | 1,215.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |